Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diagnos Inc (DGNOF)

Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
DIAGNOS Announces the Start of the Deployment of its Pathology Detection Systems in the Retail Clinics of Farmacias Benavides, a Member of Walgreens Boots Alliance

BROSSARD, Quebec, June 23, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Announces the Deployment of its Age-Related Macular Degeneration Detection Application Into the Optometry Clinics of IRIS, The Visual Group

BROSSARD, Quebec, June 07, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS and the CHUM are launching the testing phase of autonomous artificial intelligence solutions dedicated to diabetic retinopathy screening

BROSSARD, Quebec, May 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Announces a Contract with Farmacias Benavides, a Member of Walgreens Boots Alliance in Mexico

BROSSARD, Quebec, May 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Announces Closing of Private Placement and New Marketing Director

BROSSARD, Quebec, March 28, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
CAN Health Network and Quebec-Based DIAGNOS Announce Life-Changing Diabetic Retinopathy Screening Program Partnership

Innovative diabetic retina screening service resulting in earlier intervention, better care, and savings to the Canadian healthcare system....

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, March 01, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Successfully Completes ISO / MDSAP Audit

BROSSARD, Quebec, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS Provides Corporate Update for 2021 and Outlook for 2022

BROSSARD, Quebec, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)
DIAGNOS will start a clinical trial study in the USA commencing December 6th, 2021 for early detection and prevention of Stroke using CARA-STROKE.

BROSSARD, Quebec, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early...

ADK.VN : 0.300 (+1.69%)
DGNOF : 0.2031 (-4.42%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield?
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar